Elevance Health (ELV) Receivables (2009 - 2026)

Elevance Health (ELV) has 18 years of Receivables data on file, last reported at $17.8 billion in Q2 2026.

• On a quarterly basis, Receivables rose 0.78% year-over-year to $17.8 billion in Q2 2026; TTM through Jun 2026 was $17.8 billion, a 0.78% increase from a year earlier, with the FY2025 full-year figure at $16.4 billion, up 16.77% from the prior year.
• Receivables for Q2 2026 stood at $17.8 billion, up from $17.7 billion in the prior quarter.
• Over the last five years, Receivables for ELV reached as high as $17.8 billion in Q2 2026 and fell as low as $10.3 billion in Q3 2022.
• Historically, Receivables has averaged $14.1 billion across 5 years, with a median of $13.6 billion in 2023.
• Across the five-year window, Receivables soared 58.49% in 2022 and rose 0.67% in 2024, its largest moves.
• Year by year, Receivables stood at $11.4 billion in 2022, then increased by 16.92% to $13.3 billion in 2023, then climbed by 5.41% to $14.0 billion in 2024, then gained by 16.77% to $16.4 billion in 2025, then rose by 8.72% to $17.8 billion in 2026.
• Per Business Quant data, the three most recent Receivables figures were $17.8 billion in Q2 2026, $17.7 billion in Q1 2026, and $16.4 billion in Q4 2025.